Metabolic Syndrome (MS) has a very complex pathophysiology, which is only partially understood from a clinical point of view. Important risk factors are genetics, age and diet. MS already happens when three clinical conditions out of the following five occur together: abdominal obesity, high blood pressure, high blood sugar, high serum triglycerides and low serum HDL. Subjects diagnosed with MS have higher risk of developing cardiovascular diseases (CVD) and diabetes. In the last decades the incidence of MS has significantly increased worldwide, leading to a global epidemic of CVD, obesity and diabetes. MS has a multifactorial pathogenesis and a state of Oxidative Stress (OS) plays crucial roles in exacerbating MS clinical manifestations.
Cor.Con. International has rationally developed products that aim at dealing with MS-related conditions, such as elevated blood cholesterol and glucose levels, and preserving the proper systemic RedOx status.
Our innovative food supplements are patented, tested in clinical studies. The use of specific ingredients promotes the maintenance of normal blood cholesterol levels, protects the cells from oxidative stress and promotes the normal collagen formation for the normal function of blood vessels, promotes the maintenance of normal blood glucose level and the normal protein and glycogen metabolism.
Bringing an idea to the market requires both creativity and a straightforward set of processes. We identify safe active ingredients and combine them according to specificity, activity and harmonization in order to address physiological, regulatory and market needs (Rationale Design & Formulation). We demonstrate the efficacy and safety of our formulations (Claims & Safety) through scientific investigations (Clinical Studies). We collect data to protect the innovative intellectual property (Patent) and to publish scientific documents for the promotion of the products (Publication). Finally, we release a ready-to-use product through identified channels and pharmaceutical companies that bring the product to the market (Ready to Market).
Lipiban is a patented food supplement based on a combination of Polyglucosamine and Vitamin C.
Lipiban is available in tablets, it is recommended to take two tablets half an hour before main meals.
DiscoverAntilip is a patented food supplement based on a harmonized combination of polyglucosamine, phytosterols from Brassica rapa campestris, Monacolin K from Monascus purpureus and vitamin C.
Antilip is available in tablets; it is recommended to take two tablets half an hour before dinner.
DiscoverAntilip Advance is a patented food supplement based on a harmonized combination of polyglucosamine, phytosterols from Brassica rapa campestris, Monacolin K from Monascus purpureus, chromium picolinate, Vitamin C and Vitamin B6.
Antilip Advance is available in tablets; it is recommended to take two tablets half an hour before dinner.
DiscoverChitosan, also named polyglucosamine, is a linear poly-aminosaccharide. It is obtained through chitin deacetylation, which is the structural element in the exoskeleton of crustaceans (such as crabs and shrimp) and cell walls of fungi.
In 2011 EFSA granted chitosan with the claim “Chitosan contributes to the maintenance of normal blood cholesterol levels”, with the health relationship “maintenance of normal blood LDL-cholesterol concentrations”.
Discover